These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37162119)

  • 1. α-Fetoprotein in Cirrhotic Patients Can Have a Different Origin and Relationship.
    Toro A; Rapisarda M; Maugeri D; Di Carlo I
    J Am Coll Surg; 2023 Sep; 237(3):581-582. PubMed ID: 37162119
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later].
    Molina Infante J; Pérez Gallardo B; Prieto Bermejo AB; Fernández Bermejo M; Robledo Andrés P
    Gastroenterol Hepatol; 2007; 30(6):370-1. PubMed ID: 17662222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
    Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
    Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
    Senturk H; Cumali R
    Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of α-fetoprotein measurement in detection of hepatocellular carcinoma--1 more nail in the coffin.
    Giannini EG; Trevisani F
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2138-9. PubMed ID: 25014652
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
    Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
    Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model to Predict Recurrent Hepatocellular Carcinoma after Resection: Impact of α-Fetoprotein in Patients with Cirrhosis: In Reply to Toro and colleagues.
    Ding HF; Zhang XF; Pawlik TM
    J Am Coll Surg; 2023 Sep; 237(3):582. PubMed ID: 37194948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
    Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
    Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
    El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
    Llovet JM
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
    [No Abstract]   [Full Text] [Related]  

  • 16. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
    Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
    BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
    Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
    Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonographic features of hepatocellular pseudotumour in the cirrhotic liver.
    Chang YC; Nagasue N; Kimura N; Ota N; Yukaya H
    Clin Radiol; 1988 Nov; 39(6):635-8. PubMed ID: 2468438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein in liver transplantation for hepatocellular carcinoma: The lower, the better.
    Mazzaferro V; Droz Dit Busset M; Bhoori S
    Hepatology; 2018 Aug; 68(2):775-777. PubMed ID: 29425402
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
    Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
    Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.